Evidence map›Paper›PMID 25064829›Full record

ReviewMatrix biology : journal of the International Society for Matrix Biology2014

Revisiting the matricellular concept.

Joanne E Murphy-Ullrich, E Helene Sage

Abstract readReview
In one paragraph

Review in Matrix biology : journal of the International Society for Matrix Biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 236 papers.

0numbers the graph read from it
0cells of the map it votes in
236citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

236 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Cellular and molecular regulation of fibrotic postoperative abdominal adhesions.American journal of physiology. Cell physiology · 2026
    Review
  11. Research progress on blood therapy for anti-aging.Journal of advanced research · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Advances in the Targeted Drug Delivery System for Renal Fibrosis.International journal of nanomedicine · 2026
    Review
  16. TGF-β2/OPTN/FOXC1/BBA advances · 2026
    Article
  17. Review
  18. Article
  19. Review
  20. Article

176 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Joanne E Murphy-UllrichDepartment of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294-0019, United States. Electronic address: murphy@uab.edu.
E Helene Sage

Funding

FASEB SRC on Matricellular Proteins in Development, Health, and DiseaseR13DK100244 · NIDDK · FEDERATION OF AMER SOC FOR EXPER BIOLOGY · PI MURPHY-ULLRICH, JOANNE E · 2013 to 2013
$4k
NIDDK NIH HHS R13 DK100244NIDDK NIH HHS R13DK100244
6 · The paper itself

Abstract

The concept of a matricellular protein was first proposed by Paul Bornstein in the mid-1990s to account for the non-lethal phenotypes of mice with inactivated genes encoding thrombospondin-1, tenascin-C, or SPARC. It was also recognized that these extracellular matrix proteins were primarily counter or de-adhesive. This review reappraises the matricellular concept after nearly two decades of continuous investigation. The expanded matricellular family as well as the diverse and often unexpected functions, cellular location, and interacting partners/receptors of matricellular proteins are considered. Development of therapeutic strategies that target matricellular proteins are discussed in the context of pathology and regenerative medicine.

Indexed as

Alternative SplicingAnimalsBiomarkersCCN Intercellular Signaling ProteinsExtracellular Matrix ProteinsGene Expression RegulationHumansMiceModels, BiologicalOsteonectinProtein Processing, Post-TranslationalReceptors, AntigenThrombospondin 1Tissue EngineeringTranslational Research, BiomedicalBiomarkersCCN Intercellular Signaling ProteinsExtracellular Matrix ProteinsOsteonectinReceptors, AntigenThrombospondin 1Tn receptorCCNCell adhesionExtracellular matrixFibulinHevinMatricellularOsteopontinPeriostinRegenerative medicineR-spondinSPARCTenascinsThrombospondins

Identifiers

PMID25064829
PMCPMC4379989

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.